Sexuality and pharmacotherapy. Medication-induced disorders of sexual response and pharmacotherapeutic options for the treatment of sexual dysfunctions;Sexualität und pharmakotherapie. Arzneimittelinduzierte sexuelle funktionsstörungen und medikamentöse optionen zur behandlung sexueller dysfunktionen

Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz

Volumn 50, Issue 1, 2007, Pages 19-32

  Hartmann, Uwe ^a   Ruffer Hesse C ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

Induced sexual dysfunctions; Medication; Pharmacotherapy; Sexual dysfunctions; Sexual side effects

Indexed keywords

HORMONE; PSYCHOTROPIC AGENT;

CHEMICALLY INDUCED DISORDER; CLINICAL PRACTICE; DRUG EFFECT; HUMAN; METHODOLOGY; MULTIMODALITY CANCER THERAPY; PRACTICE GUIDELINE; PSYCHOSEXUAL DISORDER; REVIEW; SEXUAL COUNSELING; SEXUAL DYSFUNCTION; SEXUALITY; TREATMENT OUTCOME;

COMBINED MODALITY THERAPY; HORMONES; HUMANS; PHYSICIAN'S PRACTICE PATTERNS; PRACTICE GUIDELINES; PSYCHOTROPIC DRUGS; SEX COUNSELING; SEXUAL DYSFUNCTION, PHYSIOLOGICAL; SEXUAL DYSFUNCTIONS, PSYCHOLOGICAL; SEXUALITY; TREATMENT OUTCOME;

EID: 33846298555     PISSN: 14369990     EISSN: 14371588     Source Type: Journal    
DOI: 10.1007/s00103-007-0113-9     Document Type: Review

References (70)

1. Araujo AB, Durante R, Feldman HA (1998) The relationship between depressive symptoms and male erectile dysfunction: cross-sectional results from the Massachussetts Male Aging Study. Psychosomatic Med 60: 458-465
2. Thase ME, Howland RH (1995) Biological processes in depression: an updated review and integration. In: Beckham, EE, Leber WR (eds) Handbook of depression, 2nd edn. Guilford Press, New York, pp 213-279
3. Gregorian RS, Golden KA, Bahce A et al. (2002) Antidepressant induced sexual dysfunction. Annals Pharmacother 36: 1577-1589
4. Zajecka J (2001) Strategies for the treatment of antidepressant-related sexual dysfunction. J Clin Psychiatry 62 [Suppl 3]: 35-43
5. Balon (1999) Case Report - Sildenafil and sexual dysfunction associated with antidepressants. J Sex Marital Ther 25: 259-264
6. Nurnberg HG et al. (2000) Sildenafil in the treatment of sexual dysfunction induced by selective serotonin reuptake inhibitors: an overview. CNS Drugs, 13, No. 5: 321-335
7. Rosen R, Shabsigh R, Berber M et al. (2006) Efficacy and tolerability of vardenafil in men with mild depression and erectile dysfunction: the depression-related improvement with vardenafil for erectile response study. Am J Psychiatry 163: 79-87
8. Lewis RW, Sadovsky R, Eardley I et al. (2005) The efficacy of tadalafil in clinical populations. J Sex Medicine 2: 517-531
9. Dossenbach M, Hodge A, Anders M et al. (2005) Prevalence of sexual dysfunction in patients with schizophrenia: international variation and underestimation. Int J Neuropsychopharmacol 8: 1-7
10. Weig W (2006) Psychopharmaka und sexuelle Störungen. Blickpunkt Mann 2: 19-22
11. Weig W, Cohen S, Kühn KU, Sträter B (in Vorbereitung) Sexualstörungen bei stationär psychiatrisch behandelten Patienten - eine multizentrische Prävalenzstudie
12. Perquin L, Steinert T (2004) A review of the efficacy, tolerability and safety of sertindole in clinical trials. CNS Drugs 18 [Suppl 2]: 19-30
13. Dossenbach M, Dyachkova Y, Pirildar S et al. (2006) Effects of atypical and typical antipsychotic treatments on sexual function in patients with schizophrenia: 12-month results from the international schizophrenia outpatient health outcomes (ICSOHO) study. Eur Psychiatry 21: 251-258
14. Kinzel U, Weig W (2004) Medikamente und ihre Nebenwirkungen auf die Sexualität. Psycho Neuro 30: 53-56
15. Laumann EO, Nicolosi A, Glasser DB et al. (2005) Sexual problems among women and men aged 40-80 y: prevalence and correlates identified in the Global Study of Sexual Attitudes and Behaviors. Int J Impot Res 17: 39-57
16. American Psychiatric Association (2000) Diagnostic Criteria from DSM -IV-TR. American Psychiatric Association, Washington, D.C.
17. Guiliano F, Allard J (2001) Dopamine and sexual function. Int J Impot Res 13 [Suppl 3]: 18-28
18. Nedergaard P (1999) Dopaminergic and serotonergic control of sexual behavior. Scand J Sex 2(1): 3-11
19. Caruso S, Agnello C, Intelisano G et al. (2003) Placebo-controlled study on efficacy and safety of daily apomorphine SL intake in premenopausal women affected by hypoactive sexual desire disorder and sexual arousal disorder. Urology 63(5): 955-959
20. Bechara A, Bertolino MV, Casabe A et al. (2004) A double-blind randomized placebo control study comparing the objective and subjective changes in female sexual response using sublingual apomorphine. J Sex Med 1: 209-214
21. Zimmermann M, Posternak MA et al. (2005) Why isn't Bupropion the most frequently prescribed antidepressant? J Clin Psychiatry 66(5): 603-610
22. Gardner E, Johnston JA (1985) Bupropion - an antidepressant without sexual pathophysiological action. J Clin Psychopharmacol 5(1): 24-29
23. Crenshaw TL, Goldberg JP, Stern WC (1987) Pharmacologic modification of psychosexual dysfunction. J Sex Mar Ther 13(4): 239-252
24. Segraves RT, Clayton A, Croft H et al. (2004) Bupropion sustained release for the treatment of hypoactive sexual desire disorder. J Clin Psychopharm 24(3): 339-342
25. Segraves RT, Croft H, Kavoussi R et al. (2001) Bupropion sustained release (SR) for the treatment of hypoactive sexual desire disorder (HSDD) in nondepressed women. J Sex Mar Ther 27: 303-316
26. Modell JG, May RS, Katholi CR (2000) Effect of Bupropion-SR on orgasmic dysfunction in nondepressed subjects: a pilot study. J Sex Mar Ther 26: 231-240
27. Gitlin MJ, Suri R, Altshuler L et al. (2002) Bupropion-sustained release as a treatment for SSRI-induced sexual side effects. J Sex Mar Ther 28: 131-138
28. DeBattista C, Solvason B, Poirier J et al. (2005) A placebo-controlled, randomized, double-blind study of adjunctive bupropion sustained release in the treatment of SSRI-induced sexual dysfunction. J Clin Psychiatry 66(7): 844-848
29. Ginzburg R, Wong Y, Fader JS (2005) Effect of Bupropion on sexual function. Ann Pharmacotherapy 39: 2096-2099
30. Bartlik B, Kaplan P, Kaminetsky J et al. (1999) Medications with the potential to enhance sexual responsivity in women. Psychiatric Annals 29: 46-52
31. Gartrell N (1986) Increased libido in women receiving trazodone. A J Psychiatry 143: 781-782
32. Sullivan G (1988) Increased libido in three men treated with trazodone. J Clin Psychiatry 49(5): 202-203
33. Othmer E, Othmer SC (1987) Effect of buspirone on sexual dysfunction in patients with generalized anxiety disorder. J Clin Psychiatry 48: 201-203
34. Lauerma H (1995) A case of moclobemide-induced hyperorgasmia. Int Clin Psychopharmacol 10: 123-124
35. Pfaus JG, Shadiack A, Van Soest T et al. (2004) Selective facilitation of sexual solicitation in the female rat by a melanocortin receptor agonist. PNAS 101(27): 10201-10204
36. Wessels H, Levine N, Hadley ME et al. (2000) Melanocortin receptor agonists, penile erection, and sexual motivation: human studies with Melanotan II. Int J Imp Res 12 [Suppl 4]: 74-79
37. Diamond LE, Earle DC, Heiman JR et al. (2006) An effect on the subjective sexual response in premenopausal women with sexual arousal disorder by Bremelanotide (PT-141), a melanocortin receptor agonist. J Sex Med 3: 628-638
38. Davis S (2000) Testosterone and sexual desire in women. J Sex Educ Ther 25(1): 25-32
39. Sarrel PM (1999) Psychosexual effects of menopause: role of androgens. Am J Obstet Gynecol 180: 219-224
40. Shifren JL, Braunstein GD, Simon JA et al. (2004) Transdermal testosterone treatment in women with impaired sexual function after oophorectomy. N Engl J Med 343(10): 682-688
41. Laughlin GA, Barret-Connor E, Kritz-Silverstein D, von Muhlen D (2000) Hysterectomy, oophorectomy, and endogenous sex hormone levels in older women: the Rancho Bernardo Study. J Clin Endocrinol Metab 85: 645-651
42. Bancroft J (2002) Sexual effects of androgens in women: some theoretical considerations. Fertil Steril 77 [Suppl 4]: 55-59
43. Nathorst-Boos J, von Schoultz B (1992) Psychological reactions and sexual life after hysterectomy with and without oophorectomy. Gynecol Obstet Invest 34: 97-101
44. Sherwin BB, Gelfand M (1987) The role of androgen in the maintenance of sexual functioning in oophorectomized women. Psychosom Med 49: 397-409
45. Simon J, Braunstein G, Nachtigall L et al. (2005) Testosterone patch increases sexual activity and desire in surgically menopausal women with hypoactive sexual desire disorder. J Clin Endocrinol Metab 90(9): 5226-5233
46. Buster JE, Kingsberg SA, Aguirre O et al. (2005) Testosterone patch for low sexual desire in surgically menopausal women: a randomized trial. Obstetrics Gynecology 105(5/1): 944-952
47. Basson R (2006) Sexual desire and arousal disorders in women. N Engl J Med 354(14): 1497-1506
48. Berman JR, Berman L, Goldstein I (1999) Female sexual dysfunction: incidence, pathophysiology, evaluation, and treatment options. Urology 54: 385-391
49. Allolio B, Arlt W (2002) DHEA treatment: myth or reality? Trends Endocrinol Metab 13: 288-294
50. Spark RF (2002) Dehydroepiandrosterone: a springboard hormone for female sexuality. Fertil Steril 77: 19-25
51. Arlt W, Callies F, van Vlijmen JC et al. (1999) Dehydroepiandrosterone replacement in women with adrenal insufficiency. N Engl J Med 341: 1013-1020
52. Lovas K, Gebre-Medhin G, Trovik TS et al. (2003) Replacement of dehydroepiandrosterone in adrenal failure: no benefit for subjective health status and sexuality in a 9-month, randomized, parallel-group clinical trial. J Clin Endocrinol Metab 88: 1112-1118
53. Marthol H, Hilz MJ (2004) Weibliche sexuelle Funktionsstörungen: Klassifikation, Diagnostik und Therapie. Fortschr Neurol Psychiat 72: 121-135
54. Park K, Moreland RB, Goldstein I (1998) Sildenafil inhibits phosphodiesterase Type V in human clitoral corpus cavernosum smooth muscle. Biochem Biophysic Res Com 249: 612-617
55. Caruso S, Intelisano G, Lupo L, Agnello C (2001) Premenopausal women affected by sexual arousal disorder treated with sildenafil: a double-blind, cross-over, placebo-controlled study. B J Obstet Gyn 108: 623-628
56. Basson R, Brotto LA (2003) Sexual psychophysiology and effects of sildenafil citrate in oestrogenised women with acquired genital arousal disorder and impaired orgasm: a randomised controlled trial. BJOG 110: 1014-1024
57. Basson R, McInnes R, Smith MD et al. (2002) Efficacy and safety of sildenafil citrate in women with sexual dysfunction associated with female sexual arousal. J Womens Health Gend Based Med 11: 367-377
58. Berman JR, Berman LA, Lin H et al. (2001) Effect of sildenafil on subjective and physiologic parameters of the female sexual response in women with sexual arousal disorder. J Sex Marital Ther 27: 411-420
59. Shen WW, Urosevich Z, Clayton DO (1999) Sildenafil in the treatment of female sexual dysfunction induced by selective serotonin reuptake inhibitors. Journal of Reproducitve Medicine 44(6): 535-542
60. Nurnberg HG, Lauriello J, Hensley PL et al. (1999) Sildenafil for iatrogenic serotonergic antidepressant medication-induced sexual dysfunction in 4 patients. J Clin Psychiatry 60(1): 33-35
61. Nurnberg HG, Hensley PL, Lauriello J et al. (1999) Sildenafil for women patients with antidepressant-induced sexual dysfunction. Psychiatric Services 50 (8): 1076-1078
62. Lightner DJ (2002) Female sexual dysfunction. Mayo Clin Proc 77: 698-702
63. Rutherford D, Collier A (2005) Sexual dysfunction in women with diabetes mellitus. Gyn Endocrin 21(4): 189-192
64. Caruso S, Rugolo S, Agnello C et al. (2006) Sildenafil improves sexual functioning in premenopausal women with type 1 diabetes who are affected by sexual arousal disorder: a double-blind, crossover, placebo-controlled pilot study. Fertil Steril 85(5): 496-1501
65. Rosen RC, Philipps NA, Gendrano NC et al. (1999) Oral phentolamine and female sexual arousal disorder: a pilot study. J Sex Marital Ther 25: 137-144
66. Meston CM, Worcel M (2002) The effects of yohimbine plus l-arginine glutamate on Sexual arousal in postmenopausal women with sexual arousal disorder. Arch Sex Beh 31(4): 323-332
67. Waldinger MD (2003) Rapid ejaculation. In: Levine SB, Risen CB, Althof SE (eds) Handbook of clinical sexuality for mental health professionals. Brunner-Routledge, New York, pp 257-274
68. Porst H (2000) Manual der Impotenz. Uni-Med, Bremen
69. Sperling H, Hartmann U, Weidner W, Stief CG (2005) Erektile Dysfunktion: Pathophysiologie, Diagnostik und Therapie. Dtsch Ärztebl 102: 1664-1669
70. Montejo AL, Llorca G, Izquierdo JA, Rico-Villademoros F (2001) Incidence of sexual dysfunction associated with antidepressant agents: a prospective multicenter study of 1022 outpatients. J Clin Psychiatry 62 [Suppl 3]: 10-21